MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88. (Q40410579)
Jump to navigation
Jump to search
scientific article published on 14 December 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88. |
scientific article published on 14 December 2016 |
Statements
1 reference
MV140, a sublingual polyvalent bacterial preparation to treat recurrent urinary tract infections, licenses human dendritic cells for generating Th1, Th17, and IL-10 responses via Syk and MyD88. (English)
1 reference
C Benito-Villalvilla
1 reference
C Cirauqui
1 reference
C M Diez-Rivero
1 reference
M Casanovas
1 reference
J L Subiza
1 reference
O Palomares
1 reference
14 December 2016
1 reference
1 reference
10
1 reference
4
1 reference
924-935
1 reference
14 December 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference